Investigators found 10 main themes characterizing the differences between primary care clinics classified as high- and low-performing in distributing diabetes care.
The main difference between high- and low-performing diabetes care clinics is the adoption of approaches aimed at leveraging data-driven proactive patient outreach as a tool to intensify treatment, according to a recent study.
The investigators said that physicians should consider the results of the study, published in The Annals of Family Medicine, and the potential value that incorporating a paradigm like this can have on diabetes care.
“Perhaps there are other stages in the development of innovations for practice transformation; in the meantime, these findings should be considered by leaders interested in improving care for patients with diabetes and other chronic conditions,” wrote the investigators.
A previous study found that the measures of diabetes care outcomes did not improve from 2005 to 2016, despite a significant rise in national campaigns to improve diabetes control and an overall improvement in treatment options.
However, the percentage of Minnesota patients with diabetes who achieved optimal care increased from 12% to 45% between 2004 and 2017, differing from the rest of the nation, which plateaued at 23% from 2013 to 2016. The investigators attributed the variance to an emphasis on performance monitoring and public reporting.
In light of that study, researchers of the present analysis used quantitative data to determine what factors determine whether a Minnesota clinic are considered high- or low-performing. They distributed surveys to primary care clinics that participated in the previous study, of which 416 completed them. Respondents were asked to report whether care management processes were present and rate their clinic’s priority for improving diabetes care in the next year.
After returning the survey, clinic leaders were asked to participate in a 20-to-30-minute interview to discuss their approaches to diabetes care.
The clinics were identified as high-, middle-, or low-performing based on their scores from the Minnesota Community Measurement. From the survey results, the investigators identified 10 themes that offered insight into the factors and methods characterizing the performance groups:
The main difference between groups was that high-performing clinics were much more likely to report using proactive care compared with low-performing clinics, who either didn’t mention those strategies or cited barriers to implementing them. Middle-performing clinics mostly reported that they just starting to adopt proactive approaches or viewed them as a wish.
High-performing clinics relied on timely and accurate reports to identify individual patients that were falling behind treatment goals and address their need without waiting for them to ask or come in for a scheduled appointment.
The investigators also said that they were surprised with how few comments they received, across all performance groups, regarding effective care management processes, with the exception of distributing diabetes education.
The middle-performing group had the most comments regarding effective care management processes and had the highest scores on the survey of diabetes process, suggesting, “that a clinic can obtain good performance by implementing these processes, but to break through to high performance, a paradigm shift is needed to add proactive care,” wrote the researchers.
The investigators identified the small group of clinics used, only sampling from one state, including few low-performing clinics, and indirect measurements of socioeconomic status as study limitations. They said that their results should be considered preliminary and that future studies confirming the results need to be conducted.
Reference
Solberg LI, Peterson KA, Fu H, Eder M, Jacobson R, Carlin CS. Strategies and factors associated with top performance in primary care for diabetes: insights from a mixed methods study. Ann. Fam. Med. March 2021;19(2):110-116. doi:10.1370/afm.2646
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen